Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

Emily E Carol, Ph.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Carol EE, Spencer RL, Mittal VA. Acute Physiological and Psychological Stress Response in Youth at Clinical High-Risk for Psychosis. Front Psychiatry. 2021; 12:641762. PMID: 33679489.
  2. Johnson KA, Guyer M, Öngür D, Friedman-Yakoobian M, Kline E, Carol E, Davis B, Keshavan M. Early intervention in psychosis: Building a strategic roadmap for Massachusetts. Schizophr Res. 2021 Feb 18; 229:43-45. PMID: 33611222.
    Citations:    Fields:    
  3. Carol, EE Mittal, VA . What are the implications of psychosis risk syndrome label? A diathesis-stress conceptualization. Journal of Ethics in Mental Health. 2018; (10):1-20. View Publication.
  4. Dean DJ, Bryan AD, Newberry R, Gupta T, Carol E, Mittal VA. A Supervised Exercise Intervention for Youth at Risk for Psychosis: An Open-Label Pilot Study. J Clin Psychiatry. 2017 Nov/Dec; 78(9):e1167-e1173. PMID: 29178684.
    Citations: 6     Fields:    Translation:Humans
  5. Carol EE, Spencer RL, Mittal VA. The relationship between cannabis use and cortisol levels in youth at ultra high-risk for psychosis. Psychoneuroendocrinology. 2017 Sep; 83:58-64. PMID: 28595088.
    Citations: 3     Fields:    Translation:HumansAnimals
  6. Carol EE, Mittal VA. Corrigendum to "self-reported cannabis use is inconsistent with the results from drug-screening in youth at ultra high-risk for psychosis in Colorado" [Schizophr. Res. 157 (0) (August 2014) 317-318]. Schizophr Res. 2018 02; 192:494. PMID: 28476338.
    Citations:    Fields:    
  7. Carol EE, Spencer RL, Mittal VA. Sex differences in morning cortisol in youth at ultra-high-risk for psychosis. Psychoneuroendocrinology. 2016 10; 72:87-93. PMID: 27388688.
    Citations: 3     Fields:    Translation:Humans
  8. Dean DJ, Orr JM, Bernard JA, Gupta T, Pelletier-Baldelli A, Carol EE, Mittal VA. Hippocampal Shape Abnormalities Predict Symptom Progression in Neuroleptic-Free Youth at Ultrahigh Risk for Psychosis. Schizophr Bull. 2016 Jan; 42(1):161-9. PMID: 26113620.
    Citations: 18     Fields:    Translation:Humans
  9. Carol EE, Mittal VA. Normative adolescent experiences may confound assessment of positive symptoms in youth at ultra-high risk for psychosis. Schizophr Res. 2015 Aug; 166(1-3):358-9. PMID: 25986415.
    Citations: 4     Fields:    Translation:Humans
  10. Carol EE, Mittal VA. Resting cortisol level, self-concept, and putative familial environment in adolescents at ultra high-risk for psychotic disorders. Psychoneuroendocrinology. 2015 Jul; 57:26-36. PMID: 25880698.
    Citations: 12     Fields:    Translation:Humans
  11. Dean DJ, Kent JS, Bernard JA, Orr JM, Gupta T, Pelletier-Baldelli A, Carol EE, Mittal VA. Increased postural sway predicts negative symptom progression in youth at ultrahigh risk for psychosis. Schizophr Res. 2015 Mar; 162(1-3):86-9. PMID: 25601361.
    Citations: 23     Fields:    Translation:Humans
  12. Hooker CI, Carol EE, Eisenstein TJ, Yin H, Lincoln SH, Tully LM, Dodell-Feder D, Nahum M, Keshavan MS, Seidman LJ. A pilot study of cognitive training in clinical high risk for psychosis: initial evidence of cognitive benefit. Schizophr Res. 2014 Aug; 157(1-3):314-6. PMID: 24954429.
    Citations: 21     Fields:    Translation:Humans
  13. Carol EE, Mittal VA. Self-reported cannabis use is inconsistent with the results from drug-screening in youth at ultra high-risk for psychosis in Colorado. Schizophr Res. 2014 Aug; 157(1-3):317-8. PMID: 24924407.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  14. Dean DJ, Bernard JA, Orr JM, Pelletier-Baldelli A, Gupta T, Carol EE, Mittal VA. Cerebellar Morphology and Procedural Learning Impairment in Neuroleptic-Naive Youth at Ultrahigh Risk of Psychosis. Clin Psychol Sci. 2014 Mar; 2(2):152-164. PMID: 25419496.
    Citations: 20     
  15. Mittal VA, Dean DJ, Bernard JA, Orr JM, Pelletier-Baldelli A, Carol EE, Gupta T, Turner J, Leopold DR, Robustelli BL, Millman ZB. Neurological soft signs predict abnormal cerebellar-thalamic tract development and negative symptoms in adolescents at high risk for psychosis: a longitudinal perspective. Schizophr Bull. 2014 Nov; 40(6):1204-15. PMID: 24375457.
    Citations: 41     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Carol's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (57)
Co-Authors (5)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.